Sort
40,608 grants matching “prostate cancer”
Hybrid nanotechnology to target metastatic advanced prostate cancer
$317,475Ho-Lun Wong · Temple Univ Of The Commonwealth · R01 · FY2015 · CA
Hybrid nanotechnology to target metastatic advanced prostate cancer
$317,475Ho-Lun Wong · Temple Univ Of The Commonwealth · R01 · FY2016 · CA
Hybrid nanotechnology to target metastatic advanced prostate cancer
$317,475Ho-Lun Wong · Temple Univ Of The Commonwealth · R01 · FY2012 · CA
Tetrandrine for the treatment of Prostate Cancer
$317,475Hari K. Koul · University Of Colorado Denver · R01 · FY2012 · CA
Nutrition, Metabolism, and Cancer
$317,441Gretchen Gierach · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
FOXO1 Inhibition in Genotoxic Stress Response and Prostate Cancer Survival
$317,411Haojie Huang · Mayo Clinic Rochester · R01 · FY2012 · CA
Mechanism of promiscuous AR activation in PTEN-mutated prostate cancer
$317,411Haojie Huang · Mayo Clinic Rochester · R01 · FY2014 · CA
A Unified Machine Learning Package for Cancer Diagnosis
$317,390Linda Shapiro · University Of Washington · U01 · FY2019 · CA
Immunoliposome-Mediated Gene Therapy for Prostate Cancer
$317,330Synergene Therapeutics, Inc. · R42 · FY2003 · CA
Immunoliposome-Mediated Gene Therapy for Prostate Cancer
$317,330Synergene Therapeutics, Inc. · R42 · FY2002 · CA
Robot-Assisted Personalized Prostate Biopsy
$317,327Dan Stoianovici · Johns Hopkins University · R01 · FY2025 · CA
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
$317,240Joshi James Alumkal · Oregon Health & Science University · R01 · FY2018 · CA
Phase I/II Study of MS-275 and 5-Azacytidine in Patients with Advanced Non-Small
$317,239Charles M Rudin · Johns Hopkins University · R21 · FY2008 · CA
Targeting Hsp60 to Inhibit CREB-mediated Gene Transcription
$317,217Xiangshu Xiao · Oregon Health & Science University · R01 · FY2019 · GM
Invasion and Metastasis in Prostate Cancer
$317,129Valeri Vasioukhin · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Invasion and Metastasis in Prostate Cancer
$317,129Valeri Vasioukhin · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
QUALITY OF LIFE AMONG AFRICAN AMERICAN PROSTATE CANCER SURVIVORS AND THEIR PARTNERS: A MULTILEVEL PERSPECTIVE
$317,125The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2019 · Defense Health Agency
AR and RUNX2 target genes in prostate cancer
$317,110Gerhard A Coetzee · University Of Southern California · R01 · FY2006 · CA
Catheter-Based Ultrasound Hyperthermia System for 3D-Targeted Thermal Therapy
$317,109Chris John Diederich · University Of California, San Francisco · R01 · FY2007 · CA
Cooperative steroidogenic inhibition for treatment of advanced prostate cancer
$317,090Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · CA
Phase I/II Study of MS-275 and 5-Azacytidine in Patients with Advanced Non-Small
$317,087Charles M Rudin · Johns Hopkins University · R21 · FY2007 · CA
IMRT Guided by Magnetic Resonance Spectroscopic Imaging
$317,077Stanford University · R01 · FY2003 · CA
Prostate carcinogenesis and PKC signaling
$317,047Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2010 · CA
Discovery and mechanism of BK channel gating modulators
$317,000Brad S Rothberg · Temple Univ Of The Commonwealth · R01 · FY2021 · GM
Discovery and mechanism of BK channel gating modulators
$317,000Brad S Rothberg · Temple Univ Of The Commonwealth · R01 · FY2020 · GM